In recent years, much progress has been made in the management of stroke, which has improved the prognosis significantly. This is reflected in the results of a recent phase III Bayer clinical trial, called Oceanic-Stroke, which has been able to reduce the recurrence of a second episode by 26% after suffering an ischemic cerebrovascular infarction, without increasing the risk of bleeding. “Healthy lifestyle decreases the chance of having a stroke…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
In recent years, much progress has been made in the management of stroke, which has improved the prognosis significantly. This is reflected in the results of a recent phase III Bayer clinical trial, called Oceanic-Stroke, which has been able to reduce the recurrence of a second episode by 26% after suffering an ischemic cerebrovascular infarction, without increasing the risk of bleeding. “Healthy lifestyle decreases the chance of having a stroke…